Ai

Janssen recruits AI startup to develop blood cancer treatments

Janssen recruits AI startup to develop blood cancer treatments

By Jonathan Smith

The UK startup Intelligent OMICS (Intellomx) has launched a collaboration with Johnson & Johnson’s pharmaceutical company Janssen to use artificial intelligence (AI) to discover drug targets for the treatment of blood cancer.

© Getty Images

Cognizant to provide comprehensive approach to adopting AI

By Liza Laws

Cognizant has announced a platform that can use it consulting, advisory, ecosystem partnership along with digital studios and industry knowledge to help its clients transition to generative artificial intelligence (AI).

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All